GoldenGolden
Auspex Pharmaceuticals

Auspex Pharmaceuticals

A biopharmaceutical company that develops therapeutics to treat depressive disorders

Help us improve this page by adding information.
Visit our Writing Guide or this topic page for additional help.

Timeline

September 10, 2013
Auspex Pharmaceuticals raises a $27,992,742 series E round.
November 8, 2012
Auspex Pharmaceuticals raises a $25,000,000 series D round from CMEA Capital, Panorama Capital, Sloan Biotech Funds and Thomas, McNerney & Partners.
October 13, 2010
Auspex Pharmaceuticals raises a $12,000,000 series C round.

Funding rounds

People

Name
Role
LinkedIn

Michael Weickert

Employee

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.